Cargando…
Correction: STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269544/ https://www.ncbi.nlm.nih.gov/pubmed/32487537 http://dx.doi.org/10.1136/esmoopen-2020-000706corr1 |
Ejemplares similares
-
STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort
por: Papillon-Cavanagh, Simon, et al.
Publicado: (2020) -
STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world
por: Shire, Norah J., et al.
Publicado: (2020) -
Construction of an STK11 Mutation and Immune-Related Prognostic Prediction Model in Lung Adenocarcinoma
por: Tang, Bo, et al.
Publicado: (2023) -
Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer
por: Wohlhieter, Corrin A., et al.
Publicado: (2020) -
Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting
por: Julian, Cristina, et al.
Publicado: (2023)